References
- Amdisen A. Drug-produced Obesity Experience with Chlorpromazine, Per-phenazine and Chlorpentixol. Dan. med. Bull. 1964; 11: 182–189
- Hald A. Statistical theory with engineering applications. I. Willey & Son, New York 1960
- Hermann L. S. Biguanides and Lactate Metabolism. Dan. med. Bull. 1973; 20: 65–79
- Jensen Stigaard P., Kirk L. Fenfluramin (Ponderal®) ved behandling af adi-positas fremkaldt af neuroleptica. Nord. Psykiat. 1972; 26: 367
- Mehrotra T. N., Yuong B. A. Metformin in the Treatment of Obese Diabeties. Brit. J. clin. Pract. 1967; 21: 85
- Munro J. E., Mac Cuish A. C., Marshall A., Wilson E. M., Duncan L. J. P. Weight-reducing Effect of Diguanides in Obese Non-diabetic Women. Brit. med. J. 1969; 11: 13–15
- Muus P., Kirk L. Zinc-protamin-glucagon in the Treatment og Obesity caused by Neuroleptics. Acta psychiat. scand. suppl. 1973; 243: 68
- Natvig H. Nye høyde-vekttabeller for norske kvnner og menn. Landsforen. for Kosthold og Helse, Oslo 1956
- Parrow A. Behandling av diabetes mellitus med metformin. Läkartidn. 1968; 65: 4671–4676
- Pedersen J. The Effect of Metformin on Weight Loss in Obesity. Acta Endocrin. (Kbh.) 1965; 49: 479–486
- Pedersen J. Glukose-máielkesyremetabolisme ved klinisk anvendelse af biguanider. Ugeskr. lág. 1973; 135: 1632–1635
- Pedersen J., Olesen E. S. Observations on the Mechanism of Increased Weight Loss During Metformin Administration in Obesity. Acta endocrin. (Kbh.) 1968; 57: 683–688